Evidence mapPaperPMID 39178255Full record

ArticleScience advances2024

High-fat feeding drives the intestinal production and assembly of C

Michael Sm Mah, Enyuan Cao, Dovile Anderson, Alistair Escott, Surafel Tegegne, Gracia Gracia, Joel Schmitz, Susanne Brodesser, Colby Zaph, Darren J Creek and 6 more

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Michael Sm MahMonash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.ORCID 0009-0001-1297-0341
Enyuan CaoMonash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.ORCID 0000-0002-9689-4517
Dovile AndersonMonash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.ORCID 0000-0003-0284-471X
Alistair EscottSurgical and Translational Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Surafel TegegneMonash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.ORCID 0000-0002-3280-9117
Gracia GraciaMonash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.ORCID 0009-0000-8552-2323
Joel SchmitzMax Planck Institute for Metabolism and Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD), Cologne, Germany.
Susanne BrodesserUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Cluster of Excellence Cellular Stress Responses in Aging associated Diseases (CECAD), Cologne, Germany.ORCID 0000-0001-5631-0663
Colby ZaphBiomedical Discovery Institute, Monash University, Melbourne, Australia.ORCID 0000-0002-9889-9848
Darren J CreekMonash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
Jiwon HongSurgical and Translational Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.ORCID 0000-0003-0936-3281
John A WindsorSurgical and Translational Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Anthony Rj PhillipsSurgical and Translational Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.ORCID 0000-0001-6143-5866
Natalie L TrevaskisMonash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.ORCID 0000-0001-9538-549X
Mark A FebbraioMonash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.ORCID 0000-0002-9296-4418
Sarah M Turpin-NolanMonash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.ORCID 0000-0002-7469-7934

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consumption of a diet rich in saturated fat increases lipid absorption from the intestine, assembly into chylomicrons, and delivery to metabolic tissues via the lymphatic and circulatory systems. Accumulation of ceramide lipids, composed of sphingosine and a fatty acid, in metabolic tissues contributes to the pathogenesis of cardiovascular diseases, type 2 diabetes mellitus and cancer. Using a mesenteric lymph duct cannulated rat model, we showed that ceramides are generated by the intestine and assembled into chylomicrons, which are transported via the mesenteric lymphatic system. A lipidomic screen of intestinal-derived chylomicrons identified a diverse range of fatty acid, sphingolipid, and glycerolipid species that have not been previously detected in chylomicrons, including the metabolically deleterious C

Indexed as

CeramidesChylomicronsDiet, High-FatIntestinal MucosaAnimalsHumansIntestinesLipidomicsMaleRatsCeramidesChylomicrons

Identifiers

PMID39178255
PMCPMC11343029

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.